Alethea Capital Management, LLC Avidity Biosciences, Inc. Transaction History

Alethea Capital Management, LLC

$138 Million
Q3 2024

A detailed history of Alethea Capital Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Alethea Capital Management, LLC holds 427,454 shares of RNA stock, worth $12.9 Million. This represents 14.27% of its overall portfolio holdings.

Number of Shares

427,454

Previous 503,504 15.1%

Holding current value

$12.9 Million

Previous $20.6 Million 4.55%

% of portfolio

14.27%

Previous 15.72%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$37.21 - $48.14 $2.83 Million - $3.66 Million	-76,050 Reduced 15.1%	427,454 $19.6 Million
Q2 2024 Aug 15, 2024	SELL	$22.73 - $40.85 $5.85 Million - $10.5 Million	-257,193 Reduced 33.81%	503,504 $20.6 Million
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $860,618 - $2.4 Million	-93,954 Reduced 10.99%	760,697 $19.4 Million
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $31,500 - $56,750	5,000 Added 0.59%	854,651 $5.45 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $371,132 - $620,165	24,178 Added 2.93%	849,651 $13 Million
Q4 2022 Feb 14, 2023	SELL	$10.06 - $22.66 $100,600 - $226,600	-10,000 Reduced 1.2%	825,473 $18.3 Million
Q2 2022 Aug 15, 2022	SELL	$11.18 - $20.5 $609,131 - $1.12 Million	-54,484 Reduced 6.12%	835,473 $12.1 Million
Q1 2022 May 13, 2022	BUY	$14.2 - $23.78 $5,964 - $9,987	420 Added 0.05%	889,957 $16.4 Million
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $367,812 - $516,739	-18,030 Reduced 1.99%	889,537 $21.1 Million
Q3 2021 Oct 27, 2021	SELL	$18.16 - $25.21 $4.71 Million - $6.53 Million	-259,180 Reduced 22.21%	907,567 $22.4 Million
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $4.3 Million - $6.41 Million	-219,117 Reduced 15.81%	1,166,747 $28.8 Million
Q1 2021 May 14, 2021	SELL	$20.28 - $28.15 $3.76 Million - $5.22 Million	-185,296 Reduced 11.79%	1,385,864 $30.2 Million
Q4 2020 Feb 12, 2021	BUY	$24.73 - $35.12 $38.9 Million - $55.2 Million	1,571,160 New	1,571,160 $40.1 Million

Others Institutions Holding RNA

# of Institutions

255

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.57B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alethea Capital Management, LLC with notifications on news.

Account

Alethea Capital Management, LLC Avidity Biosciences, Inc. Transaction History